FDA Approves New Crysvita Dosing Regimen for Adults with X-Linked Hypophosphatemia

FDA Approves New Crysvita Dosing Regimen for Adults with X-Linked Hypophosphatemia

Kyowa Kirin announced that the FDA approved a dosing up […] The post FDA Approves New Crysvita Dosing Regimen for Adults with X-Linked Hypophosphatemia first appeared on GeneOnline News. The post FDA Approves New Crysvita Dosing Regimen for Adults with X-Linked Hypophosphatemia appeared first on GeneOnline News.

Kyowa Kirin secures FDA approval for Crysvita dosing update

Kyowa Kirin has received approval from the FDA for a dosing update to the Crysvita prescribing information, introducing a new option for adults with XLH.The post Kyowa Kirin secures FDA approval for Crysvita dosing update appeared first on Hospital Management.